{
    "title": "Russian firm seeks to produce COVID-19 drug remdesivir without patent",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8905401/Russian-firm-seeks-produce-COVID-19-drug-remdesivir-without-patent.html",
    "date": "2020-11-02",
    "keywords": [
        "drug",
        "punia",
        "remdesivir",
        "kremlin",
        "russia",
        "trial",
        "drugmaker",
        "pharmasyntez",
        "version",
        "director",
        "monday",
        "consent",
        "gilead",
        "covid19",
        "course",
        "moscow",
        "president",
        "patent",
        "pharmasyntezs",
        "vikram",
        "patentholder",
        "firm",
        "july",
        "form",
        "licence",
        "compulsory",
        "licensing",
        "process",
        "basis",
        "security",
        "right",
        "generic",
        "remdeform",
        "law",
        "behalf",
        "product",
        "vedomosti",
        "newspaper",
        "companys",
        "letter",
        "comment",
        "business",
        "access",
        "record",
        "coronavirus",
        "sunday",
        "number",
        "emergency",
        "use",
        "authorization",
        "food",
        "administration",
        "bout",
        "disease",
        "month",
        "world",
        "health",
        "patient",
        "register",
        "entry",
        "company",
        "market",
        "cost",
        "brand",
        "name",
        "veklury",
        "reporting",
        "polina",
        "edmund",
        "blair",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}